Author:
Chaudhary Shakun,Rastogi Ashu,Walia Rama
Publisher
Springer Nature Singapore
Reference9 articles.
1. Acharya SV, Gopal RA, George J, Bandgar TR, Menon PS, Shah NS. Utility of single luteinizing hormone determination 3 h after depot leuprolide in monitoring therapy of gonadotropin-dependent precocious puberty. Pituitary. 2009;12:335–8.
2. Bajpai A. Precocious puberty. In: Desai MP, Bhatia V, Menon PS, editors. Pediatric endocrine disorders. 1st ed. Hyderabad: Orient Longman; 2001. p. 217–41.
3. Bangalore Krishna K, Fuqua JS, Rogol AD, Klein KO, Popovic J, Houk CP, et al. Use of gonadotropin-releasing hormone analogs in children: update by an international consortium. HRP. 2019;91(6):357–72.
4. Bulsari K, Falhammar H. Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Endocrine. 2017;55(1):19–36.
5. Degros V, Cortet-Rudelli C, Soudan B, Dewailly D. The human chorionic gonadotropin test is more powerful than the gonadotropin-releasing hormone agonist test to discriminate male isolated hypogonadotropic hypogonadism from constitutional delayed puberty. Eur J Endocrinol. 2003;149:23–9.